These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30711764)
21. The development of a scale of the Guttman type for the assessment of mobility disability in multiple sclerosis. De Souza LH Clin Rehabil; 1999 Dec; 13(6):476-81. PubMed ID: 10588533 [TBL] [Abstract][Full Text] [Related]
22. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Pelletier J; Suchet L; Witjas T; Habib M; Guttmann CR; Salamon G; Lyon-Caen O; Chérif AA Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943 [TBL] [Abstract][Full Text] [Related]
23. Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: a 2-year longitudinal study. Baumstarck K; Pelletier J; Boucekine M; Auquier P; Rev Neurol (Paris); 2015 Feb; 171(2):173-80. PubMed ID: 25558798 [TBL] [Abstract][Full Text] [Related]
24. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis. Cohen JA; Krishnan AV; Goodman AD; Potts J; Wang P; Havrdova E; Polman C; Rudick RA JAMA Neurol; 2014 Nov; 71(11):1386-93. PubMed ID: 25178496 [TBL] [Abstract][Full Text] [Related]
25. Naturally occurring change in Multiple Sclerosis Walking Scale-12 scores over time in multiple sclerosis. Motl RW; Sandroff BM; McAuley E Neurodegener Dis Manag; 2018 Oct; 8(5):315-322. PubMed ID: 30226109 [TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis. Baumstarck K; Pelletier J; Butzkueven H; Fernández O; Flachenecker P; Idiman E; Stecchi S; Boucekine M; Auquier P; Eur J Neurol; 2013 Jun; 20(6):907-14, e78-9. PubMed ID: 23347258 [TBL] [Abstract][Full Text] [Related]
27. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. Block VJ; Lizée A; Crabtree-Hartman E; Bevan CJ; Graves JS; Bove R; Green AJ; Nourbakhsh B; Tremblay M; Gourraud PA; Ng MY; Pletcher MJ; Olgin JE; Marcus GM; Allen DD; Cree BA; Gelfand JM J Neurol; 2017 Feb; 264(2):316-326. PubMed ID: 27896433 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. Rotstein DL; Healy BC; Malik MT; Chitnis T; Weiner HL JAMA Neurol; 2015 Feb; 72(2):152-8. PubMed ID: 25531931 [TBL] [Abstract][Full Text] [Related]
29. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study. D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427 [TBL] [Abstract][Full Text] [Related]
30. Natural history of secondary-progressive multiple sclerosis. Tremlett H; Yinshan Zhao ; Devonshire V Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898 [TBL] [Abstract][Full Text] [Related]
31. The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients. Ivaniuk A; Solodovnikova Y; Marusich T; Son A Acta Neurol Belg; 2021 Dec; 121(6):1699-1706. PubMed ID: 32997326 [TBL] [Abstract][Full Text] [Related]
32. Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis. Braga DM; Prado GF; Bichueti DB; Oliveira EM Arq Neuropsiquiatr; 2016 Jun; 74(6):433-8. PubMed ID: 27332066 [TBL] [Abstract][Full Text] [Related]
33. Cortical lesion load associates with progression of disability in multiple sclerosis. Calabrese M; Poretto V; Favaretto A; Alessio S; Bernardi V; Romualdi C; Rinaldi F; Perini P; Gallo P Brain; 2012 Oct; 135(Pt 10):2952-61. PubMed ID: 23065788 [TBL] [Abstract][Full Text] [Related]
34. Nonsignificant associations between measures of inhibitory control and walking while thinking in persons with multiple sclerosis. Sandroff BM; Benedict RH; Motl RW Arch Phys Med Rehabil; 2015 Aug; 96(8):1518-24. PubMed ID: 25944499 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy. Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis. Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388 [TBL] [Abstract][Full Text] [Related]